Offering a comprehensive review of the neuropathology of SARS-CoV-2, Neurological Care and the COVID-19 Pandemic provides up-to-date coverage of the wide array of the pathogen's neurological symptoms and complications. Drs. Ahmad Riad Ramadan and Gamaledin Osman discuss the neuropathology of SARS-CoV-2, its neurological manifestations, and the impact the pandemic has had on the care of patients with pre-existing neurological conditions. The authors also offer an overview of emerging treatments and vaccines, as well as ways healthcare systems have reorganized in order to respond to the pandemic.
Key Features
-
Offers a thorough discussion of the impact the virus has had on the care of patients with neurological ailments, accompanied by recommendations on how to care for these patients.
-
Covers the impact of COVID-19 on patients with cerebrovascular diseases, seizures, demyelinating diseases, neuromuscular disorders, movement disorders, headache disorders, cognitive disorders, and neuro-oncological disorders.
-
Includes a detailed case study of how one healthcare system hit hard by COVID-19 successfully transformed itself to respond to the challenges imposed by the pandemic.
-
Consolidates today's available information on this timely topic into a single, convenient resource.
| ISBN | 9780323826921 |
|---|---|
| Product Format | Ebook |
| Publication Date | 2021 |
| Author Information | Edited by Ahmad Riad Ramadan, MD, Neurologist, Stroke and Neurocritical Care, Henry Ford Neuroscience Institute, Henry Ford Hospital, Detroit, Michigan and Gamaleldin Osman, MD, Epilepsy fellow at Mayo Clinic Hospital and Assistant Professor at Mayo School of Medicine, Rochester, MN, United States |
| Table of Content | 1. Fears and hopes 2. Neuropathogenesis of SARS-CoV-2 infection 3. Neurological presentations of COVID-19 4. COVID-19 and cerebrovascular diseases 5. COVID-19 and seizures 6. COVID-19 and autoimmune demyelinating diseases 7. COVID-19 and neuromuscular disorders 8. Pediatric neurology and the COVID-19 pandemic 9. Neuro-oncologic care during the COVID-19 pandemic 10. COVID-19 infection: Impaired olfaction, movement disorders, encephalopathy, and neuropsychiatric manifestations 11. COVID-19 and headache disorders 12. Treatment approach, pharmacological agents and vaccines 13. Response of healthcare systems to the pandemic Appendix: Medications |
| Publication Date | 26-08-2021 |
| Pages | 184 |
| Trim | 235 x 191 (7 1/2 x 9 1/4) |
| Stock Status | In Stock |
| deltacomm1code | Electronic Book |
Write Your Own Review
